Chandipura Virus: A Complete Medical & Diagnostic Guide by DNA Labs India

Chandipura Virus: A Complete Medical & Diagnostic Guide by DNA Labs India

Medically Reviewed by: Dr. Anya Sharma, Pediatrician Published by: DNA Labs India Health & Diagnostic Advisory Team Last Updated: July 2026

Key Facts at a Glance

CategoryClinical & Epidemiological Data
Disease NameChandipura Virus Infection
TaxonomyFamily: Rhabdoviridae | Genus: Vesiculovirus | Species: Chandipura vesiculovirus
First Identified1965 (Chandipura village, Maharashtra, India)
Primary VectorPhlebotomine sandflies (Phlebotomus and Sergentomyia species)
Primary Host DemographicsChildren under 15 years of age in rural/semi-rural environments
Major Pathological ConditionAcute Encephalitis Syndrome (AES)
Historical Mortality Rate55%–70% in severe, untreated encephalitic presentations
Vaccine StatusNo approved prophylactic vaccine currently available
Specific Antiviral CureNone; clinical intervention relies on critical supportive care
Diagnostic ModalitiesRT-PCR (acute phase), IgM capture ELISA, CSF fluid analysis

What is Chandipura Virus? Pathophysiology & Classification

Chandipura virus (CHPV) is an RNA virus belonging to the genus Vesiculovirus within the family Rhabdoviridae. Infection causes rapid breach of the blood-brain barrier, triggering neuronal apoptosis and severe neuroinflammation that manifests as Acute Encephalitis Syndrome (AES).

Chandipura virus is taxonomically classified as a member of the genus Vesiculovirus under the family Rhabdoviridae—the same broader family that includes the rabies virus. Unlike enteric or respiratory viruses, CHPV is strictly neurotropic.

Mechanism of Neurological Invasion

  1. Vector-to-Host Inoculation: Following subcutaneous transmission via a sandfly bite, the virus undergoes initial localized replication within endothelial cells and regional lymph nodes.
  2. Viremic Dissemination: High-titer viremia develops rapidly, allowing the pathogen to reach the central nervous system (CNS).
  3. Blood-Brain Barrier (BBB) Penetration: CHPV breaches the blood-brain barrier, entering neural parenchyma.
  4. Neuronal Apoptosis & AES: Viral replication within neurons initiates an acute inflammatory cascade, cellular apoptosis, and cerebral edema, resulting in the clinical diagnosis of Acute Encephalitis Syndrome (AES).

History, Outbreaks, and Public Health Surveillance

First isolated in Maharashtra in 1965, Chandipura virus is monitored in India through coordinated surveillance by the ICMR National Institute of Virology (NIV) and the National Vector Borne Disease Control Programme (NVBDCP).

The virus was first isolated in 1965 in Chandipura village, Maharashtra. Major documented epidemics occurred in central and western India (Maharashtra, Gujarat, Andhra Pradesh) in 2003–2004. Today, surveillance is managed through:

  • ICMR-NIV (National Institute of Virology): Genomic sequencing and laboratory surveillance.
  • NVBDCP (National Vector Borne Disease Control Programme): Vector control and indoor residual spraying.
  • NCDC (National Centre for Disease Control): Epidemiological field outbreak responses.

Transmission Dynamics: How Does Chandipura Virus Spread?

Chandipura virus is a vector-borne pathogen transmitted via infected female phlebotomine sandflies. Children under 15 serve as the primary human host during epidemic flare-ups.
[Infected Female Sandfly] │ ▼ (Subcutaneous Bite / Salivary Inoculation) [Human Host (Child < 15 Years)] │ ▼ (Viremic Spread within 24–48 Hours) [Central Nervous System Invasion / Brain Inflammation (AES)]
  • Primary Biological Vector: Female phlebotomine sandflies (Phlebotomus papatasi, P. argentipes).
  • No Person-to-Person Spread: No routine human-to-human transmission documented.
  • Seasonal Peaks: Monsoon and post-monsoon (July to October).

Clinical Progression and Symptoms

Infection progresses through acute febrile onset, rapid neurological transition within 24-48 hours, and severe encephalitic complications requiring pediatric intensive care.

1. Acute Febrile Phase (Onset to 24 Hours)

  • Sudden high-grade fever (>102°F/38.9°C), severe headache, persistent vomiting, myalgia.

2. Neurological Transition Phase (24 to 48 Hours)

  • Altered sensorium, new-onset convulsions, disorientation, neck stiffness.

3. Severe Encephalitic Complications

  • Cerebral edema, refractory status epilepticus, respiratory failure, coma.

Diagnostic Protocols and Molecular Testing

RT-PCR testing detects acute viral RNA, while IgM ELISA confirms antibody response. Differentiation from other AES causes is essential.
[Suspected AES Presentation] │ ┌────────────────────┴────────────────────┐ ▼ ▼ [Onset ≤ 5 Days: Molecular] [Onset > 5 Days: Serology] • RT-PCR Test (Serum/CSF) • IgM Capture ELISA • Direct RNA Amplification • Virus-specific antibody detection

1. RT-PCR Testing: Gold standard for early confirmation (1–5 days). Specimen: serum, plasma, or CSF.
2. IgM Antibody Testing: For patients presenting after the viremic window (>5 days).
3. Supportive Labs: CBC, CSF analysis, metabolic panel.

🔬 Explore RT-PCR & Serology at DNA Labs India

Clinical Management and Supportive Treatment

No specific antiviral exists. Management relies on intensive care: seizure control, intracranial pressure reduction, and ventilation.
  • ICP Management: Osmotic diuretics (mannitol), head elevation.
  • Anticonvulsants: Benzodiazepines, levetiracetam.
  • Ventilatory Support: Early intubation if GCS <8.
  • Fluid Balance: IV fluids to maintain cerebral perfusion.

Vector Control and Evidence-Based Prevention

Prevention centers on sandfly habitat eradication, DEET-based repellents, full-body clothing, and fine-mesh bed nets.

5 Core Steps to Prevent Chandipura Virus

  1. Apply Approved Insect Repellents: DEET/picaridin on exposed skin.
  2. Wear Protective Clothing: Long sleeves, trousers, socks.
  3. Use Fine-Mesh Bed Nets: Insecticide-treated nets (ITNs).
  4. Seal Structural Breeding Sites: Fill wall cracks, animal burrows.
  5. Sanitize Cattle Sheds: Remove damp organic waste.
✅ Chandipura Virus Prevention Checklist
• Screen doors/windows with fine insect mesh
• Inspect and fill indoor wall cracks
• Apply repellent before evening outdoor play
• Participate in Indoor Residual Spraying (IRS)
• Seek immediate hospital evaluation for fever with drowsiness or seizures

Comparative Analysis: Chandipura vs. Japanese Encephalitis vs. Nipah Virus

FeatureChandipura (CHPV)Japanese Encephalitis (JE)Nipah Virus (NiV)
Viral FamilyRhabdoviridaeFlaviviridaeParamyxoviridae
Primary VectorPhlebotomine sandfliesCulex mosquitoesPteropus fruit bats
Human-to-HumanNo routine spreadNoYes (respiratory/body fluids)
Target AgeChildren under 15Children & young adultsAll age groups
VaccineNo approved vaccineYes (immunization programs)No approved vaccine

Myths vs. Facts

Common Medical MythVerified Clinical Fact
Chandipura virus spreads easily from patient to patient.CHPV is vector-borne; no routine human-to-human transmission.
Every monsoon fever is a warning sign of Chandipura.Seasonal fevers commonly caused by Dengue, Malaria; lab testing required.
Standard antibiotics can cure Chandipura encephalitis.Antibiotics have no efficacy; treatment is neuro-intensive support.
Adults are biologically immune.Adults can contract the virus, though severe cases predominate in children.

Frequently Asked Questions (FAQs)

1. What is Chandipura virus?

Chandipura virus is a rare, sandfly-borne viral infection belonging to the Rhabdoviridae family, causing Acute Encephalitis Syndrome primarily in children.

2. Why is Chandipura virus considered dangerous?

It can progress from mild fever to life-threatening brain inflammation, seizures, and coma within 24–48 hours.

3. Who is most vulnerable?

Children under 15 years in rural/agricultural communities with high sandfly populations.

4. Where was it first discovered?

1965 in Chandipura village, Maharashtra, India.

5. How does it spread?

Through the bite of infected female phlebotomine sandflies.

6. Is Chandipura virus contagious?

No, there is no confirmed routine human-to-human transmission.

7. Early symptoms?

Sudden high fever, severe headache, persistent vomiting, body weakness.

8. Severe neurological symptoms?

Seizures, confusion, drowsiness, loss of consciousness, acute encephalitis.

9. How is it diagnosed?

RT-PCR (early phase) or IgM ELISA (later phase) on blood/CSF.

10. Is there a vaccine?

No approved vaccine currently available.

11. Is there a cure?

No specific antiviral; treatment is supportive hospital care.

12. Can adults contract it?

Yes, but severe outbreaks predominantly affect children.

13. How can families prevent infection?

Repellents, long-sleeved clothing, fine-mesh bed nets, sealing wall cracks.

14. When to go to the emergency room?

If a child with fever develops seizures, confusion, persistent vomiting, or extreme sleepiness.

15. Difference from Japanese Encephalitis?

CHPV spread by sandflies (no vaccine); JE spread by mosquitoes (vaccine available).

Authoritative References & Public Health Sources

1. ICMR-NIV: Standard Operating Procedures for AES Diagnosis.
2. NVBDCP: Guidelines for Prevention and Control of AES including Chandipura.
3. NCDC: CD Alert – Surveillance of Encephalitogenic Arboviruses.
4. WHO: Global Vector Control Response & Encephalitis Surveillance Guidance.

Medical Disclaimer: This clinical and educational reference guide is published by DNA Labs India solely for public health awareness and healthcare professional communication. The content does not constitute formal medical diagnosis, individualized treatment advice, or emergency triage instructions. If a patient displays acute fever, drowsiness, behavioral alteration, or seizures, seek immediate emergency evaluation at a well-equipped hospital facility.

© DNA Labs India – Advanced Molecular Diagnostics

Free Home Sample Collection

For all online bookings

100% Accurate Results

We dont use any chinese reagents

No Compramise with quality

NGS test Platform is Illumina Nova seq

Get Tested at India No1 DNA Lab

Call us now to get free genetic counselling